Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the recipient of a large growth in short interest in September. As of September 30th, there was short interest totaling 1,948 shares, a growth of 126.2% from the September 15th total of 861 shares. Based on an average trading volume of 8,598 shares, the short-interest ratio is currently 0.2 days.
Carl Zeiss Meditec Price Performance
CZMWY stock traded up $0.26 during mid-day trading on Thursday, hitting $36.98. 1,693 shares of the company were exchanged, compared to its average volume of 4,162. The firm has a fifty day simple moving average of $35.80 and a 200 day simple moving average of $32.75. Carl Zeiss Meditec has a twelve month low of $26.65 and a twelve month high of $55.94.
Analysts Set New Price Targets
CZMWY has been the subject of several recent research reports. Morgan Stanley assumed coverage on shares of Carl Zeiss Meditec in a research report on Wednesday, September 2nd. They issued an “underweight” rating for the company. Zacks Research raised Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a research report on Tuesday, October 6th. The Goldman Sachs Group cut Carl Zeiss Meditec from a “hold” rating to a “sell” rating in a research note on Monday, October 5th. Finally, UBS Group downgraded Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a report on Tuesday, August 11th. Two investment analysts have rated the stock with a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Strong Sell”.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a Germany-based medical technology company focused on ophthalmology and microsurgery. The company develops and manufactures equipment, systems and related solutions used by physicians and hospitals for diagnosing and treating eye conditions, as well as for other surgical procedures.
Its ophthalmic portfolio includes diagnostic and imaging systems, laser systems for refractive and cataract surgery, surgical microscopes, visualization technologies and intraocular lenses.
Recommended Stories
- Five stocks we like better than Carl Zeiss Meditec
- Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?
- Failed Breakout in Tech? 3 Sectors Leading the Market Rotation
- Solaris Rides the AI Boom as Risks Mount
- Big Banks Report Strong Earnings—So Why Are Shares Falling?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
